Zariat Mushfique of DOT
[2] Claiming it worked very well in curing COVID-19 patients at a minimal cost, experts concerned were asked to quicken examinations of efficacy of a two-drug combination developed recently by a team led by a senior Bangladeshi doctor, reports The Daily Sun. [3] Director General of Directorate General of Health Services (DGHS) Prof Abul Kalam Azad told journalists, “Studies are underway in line with medical protocols and we have asked experts concerned to expedite it on an urgent basis,” reports BSS. [4] The two medicines, Ivermectin and doxycycline, are to be prescribed for “limited-scale application” among COVID-19 patients once the DGHS technical study team gave the green light about the effectiveness of the combination.
[4] Azad stated that ahead of a massive-scale application or widened use to treat COVID-19 patients, the combination would have to exhaust clinical trials by regulatory Bangladesh Medical Research Council (BMRC).
[5] Health ministry’s additional secretary Habibur Rahman said, “These are low-cost drugs, Bangladesh will be proud, if the combination is proven effective against the coronavirus.”